Adefovir and lamivudine combination therapy is superior to ADV monotherapy for lamivudine-resistant patients with HBeAG-negative chronic hepatitis B
暂无分享，去创建一个
M. Levrero | P. Lampertico | E. Sagnelli | G. Raimondo | M. Brunetto | T. Santantonio | P. Andreone | A. Marzano | S. Fagiuoli | G. Mazzella | V. Marco | A. Ascione | G. Gaeta